(Press-News.org) Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel -- undetected by normal cells -- through the bloodstream until activated by specific cancer proteins. The drug, made from a weedlike plant, has been shown to destroy cancers and their direct blood supplies, acting like a "molecular grenade," and sparing healthy blood vessels and tissues.
In laboratory studies, researchers said they found that a three-day course of the drug, called G202, reduced the size of human prostate tumors grown in mice by an average of 50 percent within 30 days. In a direct comparison, G202 outperformed the chemotherapy drug docetaxel, reducing seven of nine human prostate tumors in mice by more than 50 percent in 21 days. Docetaxel reduced one of eight human prostate tumors in mice by more than 50 percent in the same time period.
In a report June 27 in the journal Science Translational Medicine, the researchers also reported that G202 produced at least 50 percent regression in models of human breast cancer, kidney cancer and bladder cancer.
Based on these results, Johns Hopkins physicians have performed a phase I clinical trial to assess safety of the drug and have thus far treated 29 patients with advanced cancer. In addition to Johns Hopkins, the University of Wisconsin and the University of Texas-San Antonio are participating in the trial. A phase II trial to test the drug in patients with prostate cancer and liver cancer is planned.
The drug G202 is chemically derived from a weed called Thapsia garganica that grows naturally in the Mediterranean region. The plant makes a product, dubbed thapsigargin, that since the time of ancient Greece has been known to be toxic to animals. In Arab caravans, the plant was known as the "death carrot" because it would kill camels if they ate it, the researchers noted.
"Our goal was to try to re-engineer this very toxic natural plant product into a drug we might use to treat human cancer," says lead study author Samuel Denmeade, M.D., professor of oncology, urology, pharmacology and molecular sciences. "We achieved this by creating a format that requires modification by cells to release the active drug."
By disassembling thapsigargin and chemically modifying it, the researchers created a form that Denmeade likens to a hand grenade with an intact pin. The drug can be injected and can travel through the bloodstream until it finds the site of cancer cells and hits a protein called prostate-specific membrane antigen (PSMA). PSMA is released by cells lining tumors of the prostate and other areas, and in effect "pulls the pin" on G202, releasing cell-killing agents into the tumor and the blood vessels that feed it, as well as to other cells in the vicinity.
Specifically, G202 blocks the function of a protein called the SERCA pump, a housekeeping protein necessary for cell survival that keeps the level of calcium in the cell at the correct level, the researchers report.
"The exciting thing is that the cancer itself is activating its own demise," says senior study author John Isaacs, Ph.D., professor of oncology, urology, chemical and biomedical engineering at Johns Hopkins.
Because the drug is targeted to the SERCA pump, which all cells need to stay alive, researchers say it will be difficult for tumor cells to become resistant to the drug, because they cannot stop making the protein.
###
The study's co-authors were Annastasiah M. Mhaka, D. Marc Rosen, W. Nathaniel Brennen, Susan Dalrymple, Bora Gurel, Angelo M. DeMarzo, and Michael Carducci of Johns Hopkins; Ingrid Dach, Claus Olesen, Jesper V. Møller, and Poul Nissen of the Danish National Research Foundation and Aarhus University; and Craig A. Dionne of GenSpera Inc.; and S. Brøgger Christensen of the University of Copenhagen.
The work was supported by the Department of Defense Prostate Cancer Research Program, the Prostate Cancer Foundation and David Koch, the Danish Cancer Society, the Danish Research Council for Strategic Research, the Danish National Research Foundation, the Danish Medical Research Council, the Aarhus University Research Foundation, and the National Institute of Health's National Cancer Institute Specialized Program of Research Excellence (CA058236 and CA006973).
Denmeade and Isaacs are consultants for GenSpera Inc. and have received equity and financial compensation. This relationship has been disclosed and is under the management of the Johns Hopkins University School of Medicine Conflict of Interest Committee.
On the Web:
www.hopkinscancer.org
Science Translational Medicine
END
CAIRNS, Australia and STANFORD, California – 9 July 2012 -- Like their warrior ancestors, leaders of many Pacific Island nations have been making efforts to safeguard their countries, this time by sounding an alarm as the impact of climate change becomes more apparent. Today their efforts received a big boost with the release of a Scientific Consensus Statement on Climate Change and Coral Reefs that is supported by over 2,400 scientists, showing the threats that reef corals are under across the globe and calling for governments worldwide to take steps to protect valuable ...
Many of the predictions we make in everyday life are vague, and we often get them wrong because we have incomplete information, such as when we
predict the weather.
But in quantum mechanics, even if all the information is available, the
outcomes of certain experiments generally can't be predicted perfectly beforehand.
This inability to accurately predict the results of experiments in
quantum physics has been the subject of a long debate, going back to
Einstein and co-workers, about whether quantum mechanics is the best way
to predict outcomes.
Researchers from ...
Alzheimer's disease is one of the most dreaded and debilitating illnesses one can develop. Currently, the disease afflicts 6.5 million Americans and the Alzheimer's Association projects it to increase to between 11 and 16 million, or 1 in 85 people, by 2050.
Cell death in the brain causes one to grow forgetful, confused and, eventually, catatonic. Recently approved drugs provide mild relief for symptoms but there is no consensus on the underlying mechanism of the disease.
"We don't know what the problem is in terms of toxicity," said Joan-Emma Shea, professor of chemistry ...
There are two hurricanes in the Eastern Pacific today, Daniel and Emilia. NASA's TRMM satellite passed over both storms in pinpointed the intensity of the rainfall within each storm, indicative of their power. Emilia is dropping rain at a greater rate than Daniel according to satellite data.
Tropical storm Daniel strengthened and became the third hurricane over the weekend, and today, Monday, July 9, Tropical Storm Emilia strengthened into the fourth hurricane of the season. Tropical storm Emilia formed on July 7 as tropical depression 5E and became a tropical storm on ...
MADISON- A study of university students is the first evidence to refute the supposed link between depression and the amount of time spent on Facebook and other social-media sites.
The University of Wisconsin School of Medicine and Public Health study suggests that it may be unnecessarily alarming to advise patients and parents on the risk of "Facebook Depression" based solely on the amount of Internet use. The results are published online today in the Journal of Adolescent Health.
Last year, the American Academy of Pediatrics released a report on the effects of social ...
Cryptology is one of the most important techniques in the field of information security, which provides an abundance of services including privacy, data integrity, authentication, access control, anonymity, non-repudiation. The high level of security, efficiency and ease of implementation of a cryptosystem are the main design aims of cryptographers. Prof. ZHANG Huanguo and his group from Key Laboratory of Aerospace Information Security and Trusted Computing of Ministry of Education, Wuhan University, have been undertaking research on a entirely new cryptography—Evolutionary ...
STANFORD, Calif. — Government-funded community health centers, which serve low-income and uninsured patients, provide better care than do private practices, a researcher at the Stanford University School of Medicine has found.
Randall Stafford, MD, PhD, professor of medicine at the Stanford Prevention Research Center, and colleagues at University of California, San Francisco looked at the actions physicians took when patients visited private practices versus the actions that were taken at community health centers, also referred to as Federally Qualified Health Centers ...
New research reveals that rheumatoid arthritis (RA) patients do not receive fewer cancer screening tests than the general population. Results of the study, funded in part by grants from the National Institutes of Health (NIH) and published in Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR), found that RA and non-RA patients receive routine screening for breast, cervical, and colon cancer at similar rates.
The ACR estimates that 1.3 million adult Americans are affected by RA—a chronic autoimmune disease characterized by systemic inflammation ...
7/10/12, Zurich, Switzerland. Research to be presented at the Annual Meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, suggests that both animals and humans find multiple pieces of food to be more satiating and rewarding than an equicaloric, single-piece portion of food.
Increases in portion size lead to increased intake. We investigated here the impact of number and size of food .Both humans and animals use number as a cue to judge quantities of food, with larger numbers ...
7/10/12, Zurich, Switzerland. Research to be presented at the Annual Meeting of the Society for the Study of Ingestive Behavior (SSIB) the foremost society for research into all aspects of eating and drinking behavior suggests that, not only the amount and type of food eaten but the time of day it is eaten, is important in contributing to obesity.
Previous studies have shown that when mice consumed all of their calories during their inactive period they gained more weight than when they consumed the same amount of calories during their active period. A team led by Drs. ...
